Prescient Therapeutics Limited (AU:PTX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Prescient Therapeutics Limited has announced the appointment of Dr. Gavin James Shepherd as a Director on July 4, 2024. The initial director’s interest notice reveals that Dr. Shepherd has indirect interests in the company through the Shepherd Investment Trust and TPJ Superannuation Fund, with holdings of 6,150,000 and 10,000,000 securities respectively. No direct holdings or interests in contracts were reported at this time.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.